Oxidation of LDL and its clinical implication

Area of Science:

• Immunology
• Cardiovascular Research
• Atherosclerosis Pathogenesis

Background:

• Oxidative modification of low-density lipoprotein (oxLDL) is an early event in atherosclerosis.
• oxLDL formation involves lipid peroxidation, promoting inflammation and macrophage foam cell development.
• oxLDL can form complexes with beta(2)-glycoprotein I (beta(2)GPI) and C-reactive protein (CRP).

Purpose of the Study:

• To review the clinical significance of LDL oxidation, oxLDL complex formation, and autoantibodies in atherosclerotic and autoimmune diseases.
• To explore the role of autoantibodies against oxLDL/beta(2)GPI complexes in systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS).
• To discuss the pro-atherogenic potential of IgG autoantibodies and the potential protective role of natural IgM antibodies against oxLDL.

Main Methods:

• Review of recent scientific literature on LDL oxidation, oxLDL complexes, and autoantibodies.
• Analysis of findings in human patients with SLE/APS and in the NZWxBXSB F1 mouse model.
• Investigation of monoclonal IgG autoantibody (WB-CAL-1) effects on macrophage uptake of oxLDL/beta(2)GPI complexes.

Main Results:

• Autoantibodies against oxLDL/beta(2)GPI complexes correlate with arterial thrombosis in SLE/APS patients.
• Monoclonal IgG autoantibody WB-CAL-1 enhances in vitro uptake of oxLDL/beta(2)GPI complexes by macrophages, suggesting a pro-atherogenic role.
• Natural IgM anti-oxLDL antibodies in atherosclerosis-prone mice are proposed to be protective, though their human significance is unclear.

Conclusions:

• Oxidized LDL and associated autoantibodies are significant factors in atherosclerosis and autoimmune diseases.
• IgG autoantibodies against oxLDL/beta(2)GPI complexes may be pro-atherogenic, while IgM antibodies might be protective.
• Further research is needed to clarify the exact pathophysiological roles of these autoantibodies in human disease.